Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

819
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
819
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

941
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
941

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-invasive ventilation support during feeding tube placement in amyotrophic lateral sclerosis patients with moderate to severe ventilatory impairment: an update.

Panminerva medica·2026
Same author

Home mechanical ventilation in adults: Clinical practice recommendations from the Portuguese Respiratory Society home mechanical ventilation assembly.

Pulmonology·2025
Same author

Continuous Ventilatory Support Without Hospitalization or Tracheotomies: A Retrospective Observational Study of Two Centers' Outcomes for Duchenne Muscular Dystrophy.

American journal of physical medicine & rehabilitation·2025
Same author

Dr Augusta Strongman Alba 1924-2024, Homage to a PM&R Legend.

American journal of physical medicine & rehabilitation·2025
Same author

Details Matter: The Difference Between NIV and NVS.

Muscle & nerve·2025
Same author

Dr. Augusta Strongman Alba 1924-2024, Homage to a PM&R.

American journal of physical medicine & rehabilitation·2025

Related Experiment Video

Updated: Jun 29, 2025

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

60.8K

Spinal Muscular Atrophy Mortality Despite Novel Medications: Case Reports.

John R Bach1, Nayara Conceição, Miguel R Goncalves

  • 1From the Department of Physical Medicine and Rehabilitation, Rutgers University New Jersey Medical School, Newark, New Jersey (JRB); UnIC/RISE Cardiovascular R&D Unit, Faculty of Medicine, University of Porto, Porto, Portugal (NC, MRG); and Noninvasive Ventilatory Support Unit, Pulmonology Department, CAI_Vent: Home Mechanical Ventilation Program, São João University Hospital, Porto, Portugal (MRG).

American Journal of Physical Medicine & Rehabilitation
|March 26, 2024
PubMed
Summary

Patients with spinal muscular atrophy (SMA) may not receive optimal respiratory support. Noninvasive methods like mechanical insufflation-exsufflation could prevent tracheotomies and improve outcomes for SMA patients.

More Related Videos

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.1K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.7K

Related Experiment Videos

Last Updated: Jun 29, 2025

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

60.8K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.1K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.7K

Area of Science:

  • Neurology
  • Pulmonology
  • Pediatrics

Background:

  • Patients with spinal muscular atrophy (SMA) types 1-3 often experience inadequate cough flows, increasing the risk of acute respiratory failure.
  • Intubated patients with SMA who cannot be weaned from ventilators are typically presumed to require tracheostomy.
  • This presumption can lead to the discontinuation of potentially life-saving medications and adverse patient outcomes.

Purpose of the Study:

  • To evaluate the potential of noninvasive ventilatory support, specifically mechanical insufflation-exsufflation (MIE), as an alternative to tracheotomy in medically treated children with SMA type 1.
  • To highlight the underutilization of MIE despite evidence of its high success rate in similar patient populations.

Main Methods:

  • Case series presentation of three children with SMA type 1 who received medical treatment and physical strengthening.
  • Review of respiratory support strategies employed, focusing on the absence of attempts at extubation to noninvasive settings or MIE.
  • Comparison with existing literature on MIE success rates for extubating ventilator-unweanable SMA patients.

Main Results:

  • All three presented cases of medically treated children with SMA type 1 ultimately died or required tracheotomy.
  • No extubation attempts to noninvasive ventilatory support or MIE were documented in these cases.
  • Literature suggests MIE has over 98% success in extubating ventilator-unweanable, medically untreated SMA type 1 children.

Conclusions:

  • The current management of ventilator-dependent children with SMA type 1 may not fully explore noninvasive respiratory support options.
  • Mechanical insufflation-exsufflation represents a potentially underutilized, highly successful strategy for extubation in this vulnerable population.
  • Further investigation and implementation of MIE could improve respiratory outcomes and potentially reduce the need for tracheotomy in SMA patients.